Kevin V. Brandao - Publications

Interpreting perioperative oliguria during sevoflurane anesthesia: excretory physiology, fluid responsiveness, and renal endpoints.

Journal: Journal of anesthesia

Published: June 09, 2026

From clinical to immunologic remission in lupus nephritis: Toward MRD-grade B-cell depletion.

Journal: Lupus

Published: June 03, 2026

Hemodialysis catheter lock therapy beyond composition: How tip design and fluid dynamics shape delivered exposure, efficacy, and safety.

Journal: The journal of vascular access

Published: June 01, 2026

Renal toxicity during VEGF-pathway inhibition in cancer: a practical review of proteinuria, hypertension, and kidney-limited thrombotic microangiopathy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 16, 2026

Incretin therapy and transplant readiness: Distinguishing BMI-based access from physiologic reserve in solid organ transplantation.

Journal: Transplantation reviews (Orlando, Fla.)

Published: May 12, 2026

Postpartum kidney assessment after hypertensive disorders of pregnancy: A practical framework for obstetric care.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: April 13, 2026

GLP-1 receptor agonists in ADPKD: from metabolic rationale to phenotype-enriched translational testing.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 11, 2026

Renal consequences of complex abdominal wall reconstruction.

Journal: Hernia : the journal of hernias and abdominal wall surgery

Published: April 07, 2026

Improving the Cardiorenal Usability of Endothelin Receptor Antagonism in Albuminuric Chronic Kidney Disease: A Testable Role for SGLT2 Inhibitor-based Mitigation of Fluid Retention.

Journal: Cardiovascular drugs and therapy

Published: April 03, 2026

Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: March 31, 2026

Peri-Transplant APOL1 Pore Inhibition in High-Risk Donor Kidneys: A Testable Hypothesis.

Journal: Nephron

Published: March 11, 2026

From daily burden to scheduled protection: the "vaccine-like" shift in hypertension.

Journal: Journal of human hypertension

Published: February 23, 2026